Skip to content
Screener

Personalis, Inc. PSNL Financing Cash Flow

Financing Cash Flow at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
-$229M+21.8%
NeoGenomics logo
NeoGenomicsNEO
-$12.24M+94.0%
Illumina logo
IlluminaILMN
-$129M+65.2%
Veracyte logo
VeracyteVCYT
-$6.63M-2.2%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
$6.24M-36.3%
Guardant Health logo
Guardant HealthGH
-$21.58M+67.7%

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.51B+279%
Enterprise value$1.48B+283%
P/S23.4×+18.5×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Reported directly by Personalis, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: Personalis, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211896
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Repayments of loans and finance leases(1,278)(308)
Payments for finance lease buyout(2,125)
Proceeds from issuance of common stock under equity incentive plans281132
Net cash provided by financing activities17,83020,087
Effect of exchange rates on cash, cash equivalents and restricted cash92
Net change in cash, cash equivalents and restricted cash(50,651)(20,414)
Cash, cash equivalents and restricted cash, beginning of period126,03593,205
Cash, cash equivalents and restricted cash, end of period$75,384$72,791

Item 1. Financial Statements

FAQ

What is Personalis, Inc.'s financing cash flow?
Personalis, Inc. (PSNL) reported financing cash flow of $17.83M in Q1 2026.
How has Personalis, Inc.'s financing cash flow changed year-over-year?
Personalis, Inc.'s financing cash flow decreased by 11.2% year-over-year, from $20.09M to $17.83M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about Personalis, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude